What does Biotech Turnaround Fund (BTF) invest in?
Biotech Turnaround Fund (BTF) invests most often at Series D and Venture (80% of the rounds on record).
Netherlands · Investor
Last cheque observed Jan 2008. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
QuietGrowth equity
5 rounds on record
Mostly Series D and Venture: 80% of its rounds
Every round we can evidence, newest first5 appearances
1 round
2 rounds
1 round
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The investors most often in the same rounds as Biotech Turnaround Fund (BTF). A count of rooms they were both in, not a relationship either has claimed.
Biotech Turnaround Fund (BTF) invests most often at Series D and Venture (80% of the rounds on record).
5 investments on record, 0 of them in the last 12 months. The most recent was in Jan 2008.
The median round it joins is $27M.
Rarely, if at all: none of its 5 investments on record names it as the lead.
Most of the companies it backs are in Canada (60%) and the United States (40%).
No investments in the last 12 months; the latest was in Jan 2008.
Most often Bay City Capital (2 rounds together) and HBM BioVentures (2 rounds together).
Biotech Turnaround Fund (BTF) is a growth equity firm based in Netherlands.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it